Additionally, investigation on human post-mortem brains of AD patients yielded reduced protein amounts of ADAMTS4 and 5, and complete absence of ADAMTS9, pointing to a malfunction of PN component degradation [106]. The gene discussed is ADAMTS9; the disease is Alzheimer disease.